Rolapitant is a pharmaceutical active pharmaceutical ingredient (API) that functions as a selective NK1 receptor antagonist. It is used as an antiemetic in the management of chemotherapy-induced nausea and vomiting (CINV).
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Rolapitant?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Rolapitant hydrochloride hydrate
pharmaceutical raw material
Propentofylline
pharmaceutical raw material
Praziquantel
pharmaceutical raw material
Tiamulin fumarate
pharmaceutical raw material
Beclomethasone dipropionate
pharmaceutical raw material
The international HS code for Rolapitant (CAS 552292-08-7) is 2933.79.
2933.79
2933 79 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(5S,8S)-8-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-1,9-diazaspiro[4.5]decan-2-one
FIVSJYGQAIEMOC-ZGNKEGEESA-N
C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC[C@]2(CC[C@]3(CCC(=O)N3)CN2)C4=CC=CC=C4
Sourcing Rolapitant?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.